Through Manpower Minister Circular Letter No. M/11/HK.04/X/2020, the central government of Indonesia requests all provincial governors not to raise the minimum wages for 2021 as the impact of the COVID-19 crisis on entrepreneurs and business has been severe. The financial pressure (due to missed income) makes it tough for many entrepreneurs to survive. By not raising the minimum wages in 2021, these business-owners would get some air, which means jobs can be saved.
The Business Columns section of Indonesia Investments provides in-depth columns that exhibit an analysis regarding subjects that are both important for understanding the Indonesian business climate and have high news value in the current state of Indonesia's economy. As a whole these columns should provide the reader a thorough and detailed picture of multiple Indonesian business sectors and be a source of ideas or inspiration to invest - or not to invest - in specific sectors of the Indonesian economy.
On 28 August 2020 Indonesian President Joko Widodo officially opened Yogyakarta International Airport (YIA), a brand new airport that is located in Kulon Progo in the Special Region of Yogyakarta; a region known as one of Indonesia’s main tourism centers. Many in fact call Yogyakarta the ‘heart and soul of Indonesia’.
Those who have visited Indonesia should be well aware of the lack of infrastructure development across the country. Those who have been in urban centers (such as the capital city of Jakarta, Bandung or Surabaya) must have had the experience of being stuck in traffic as the number of road users (mostly cars and motorcycles) outpaces available road surface.
The pharmaceutical industry has been a center of focus in the coronavirus (COVID-19) crisis because it has an important role to play. This industry discovers, develops, produces, and markets (pharmaceutical) drugs for use as medications, with the aim to cure the patients, vaccinate them, or alleviate the symptoms. Hence, developing a vaccine or cure to COVID-19 is the responsibility of the pharmaceutical industry.
The views expressed in these business columns are the views of the authors or the interviewed persons only and therefore do not necessarily reflect the views of Indonesia Investments. The authors are free to ventilate their opinions about the Indonesian business climate. Facts presented in these columns are the result of the author's own research or indicated sources, read disclaimer.